Hong Kong Healthcare Firm Posts 4.6% Interim Profit Rise, Eyes Bay Area Integration
SingTao · 1 SOURCES1 day ago2 MIN
Summary
Hong Kong medical services provider QualiMed Health (stock code: 3886) reported interim profit of HK$37.24 million for the first half of 2024, marking a 4.6% year-on-year increase when accounting for other net gains and losses. Chairman and CEO Jonathan Choi Ka-chan expressed a cautious yet positive outlook on the long-term development of the Hong Kong and mainland medical markets, positioning the company to leverage opportunities from Greater Bay Area integration. Revenue declined 2.7% year-on-year to HK$877 million, though mainland operations showed robust 8.9% growth.
Key Points
- QualiMed recorded net profit of HK$12.9 million in the first half, up 1.4% year-on-year, with financing cost reductions driving the improvement
- Total comprehensive profit including other gains and losses reached HK$37.24 million, representing a 4.6% increase
- The company operates 415 medical service points across Hong Kong and mainland, with a network of 792 doctors, dentists and allied health professionals
- Hong Kong medical services generated HK$340 million in revenue while medical network management contributed HK$220 million
- Mainland hospital management and medical services revenue grew 8.9% to HK$310 million despite challenges including resource integration and cost control pressures
Why It Matters
The company's strategic focus on Greater Bay Area integration reflects a broader trend among Hong Kong medical operators seeking to capitalize on cross-border healthcare demand. With cross-border consumer and medical-seeking behavior continuing to reshape the private healthcare landscape, QualiMed's expansion of multi-consultation centers and extended operating hours positions it to capture market share while addressing service capacity constraints in the densely populated region .
The company's strategic focus on Greater Bay Area integration reflects a broader trend among Hong Kong medical operators seeking to capitalize on cross-border healthcare demand. With cross-border consumer and medical-seeking behavior continuing to reshape the private healthcare landscape, QualiMed's expansion of multi-consultation centers and extended operating hours positions it to capture market share while addressing service capacity constraints in the densely populated region .